On 14th January 2025, the “Pioneering Innovation & Thriving Excellence” — Tailin Bioengineering’s 5th Listing Anniversary and 2024 Annual Awards Ceremony commenced in a warm and grand atmosphere.
The road to innovation is long, but it is traveled by those who never tire; the journey toward our dreams is fueled by those who walk in unity. By daring to be pioneers and embracing our role as industry benchmarks, we continue to lead both our era and our industry.
Amid warm applause, Chairman Mr. Ye Dalin took the stage to deliver the opening remarks. Reflecting on the company’s achievements amidst a competitive 2024 landscape, he noted:
“The past year presented numerous challenges, yet through unyielding perseverance and an innovative mindset, we have consistently surpassed our goals. These achievements are a testament to the hard work of every employee and the steadfast support of our partners across society.”
Chairman Ye emphasized that 2025 marks the final year of Tailin’s first Five-Year Plan, a milestone for achieving high-quality corporate development. Looking toward the next five years, the company will maintain a steady-state growth strategy while prioritizing:
Institutional Innovation: Driving efficiency through structural evolution.
New Development Philosophy: Fully integrating into the modern global industrial landscape.
Execution Excellence: Turning our blueprint for high-quality development into reality through practical action and confidence.
Where there is great ambition, there is an opportunity to lead. Looking back at 2024, the Tailin team navigated market shifts with precision, setting the standard for the industry and fostering deep collaborations. As we enter 2025, the entire Tailin workforce remains guided by our core strategic plan. With a commitment to our founding mission, we are accelerating toward our next five-year objectives, ready to embrace the opportunities of a new era.
More info: Tailin’s 5th Anniversary of Listing Event | YouTube
